Telescope Innovations Corp (TELIF) Price & Analysis
TELIF Stock Chart & Stats
- Day’s Range
- $0.21 - $0.23
- 52-Week Range
- $0.20 - $0.77
- Previous Close
- $0.23
- Volume
- 64.79K
- Average Volume (3M)
- 100.77K
- Market Cap
- $17.64M
- Enterprise Value
- $48.58T
- Total Cash (Recent Filing)
- $1.33M
- Total Debt (Recent Filing)
- $2.71M
- Price to Earnings (P/E)
- 5.7
- Beta
- -0.03
- Next Earnings
- Dec 18, 2026
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Rapid TTM Revenue Growth
The sharp TTM revenue increase indicates that the company is expanding its reported top line and gaining commercial activity. If retained, this growth can create operating leverage and provide a broader base from which management may improve profitability over the next several quarters.
Recurring Revenue Growth History
Revenue growth is not described as a single isolated quarter; the annual history also shows expansion, albeit from a small base. Continued growth would support greater scale and could improve the company’s ability to absorb fixed costs if margins recover alongside increasing sales.
Improving Moderate Leverage
Debt-to-equity has improved from the prior annual period and remains characterized as moderate rather than extreme. This gives the company somewhat more balance-sheet flexibility than before, although continuing losses could still weaken that advantage and increase future funding needs.
Bears Say
Very Weak Profitability
Extremely low gross margin and deeply negative operating and net margins show that current revenue is not translating into sustainable earnings. This weakens the quality of growth, limits internally generated funding, and suggests that substantial cost improvements are needed before scale can create durable profit.
Material Cash Burn
The deterioration from modestly positive annual operating cash flow to strongly negative TTM operating and free cash flow indicates rising funding dependence. Persistent cash burn can restrict investment choices and increase the likelihood of borrowing or equity financing to sustain operations.
Ongoing Losses And Negative Returns
A deeply negative return on equity, combined with recurring annual losses, indicates that shareholder capital is not currently producing positive earnings power. This weak financial productivity can prolong the path to self-funding and raises the risk of dilution or additional borrowing.
Telescope Innovations Corp News
TELIF FAQ
What was Telescope Innovations Corp’s price range in the past 12 months?
What is Telescope Innovations Corp’s market cap?
When is Telescope Innovations Corp’s upcoming earnings report date?
How were Telescope Innovations Corp’s earnings last quarter?
Is Telescope Innovations Corp overvalued?
Does Telescope Innovations Corp pay dividends?
What is Telescope Innovations Corp’s EPS estimate?
How many shares outstanding does Telescope Innovations Corp have?
What happened to Telescope Innovations Corp’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Telescope Innovations Corp?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Telescope Innovations Corp
Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries. Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. has a development and collaboration agreement with AGI Group's Synthesis, Digitization, and Automation program to develop the next generation of automation- and AI-ready chemical reactor technology. Telescope Innovations Corp. is based in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Henry Dubina
- Employees
- 22
- Website
- www.telescopeinnovations.com
- Address
- 301 - 2386 East Mall, Vancouver, BC, V6T 1Z3, CA
Telescope Innovations Corp (TELIF) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 5 | 13 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 1 | 0 | 11 |







